LUCA Science operates on the frontier of a novel branch of mitochondrial therapeutics applying its proprietary production technologies to various mitochondria related disease. Its mitochondrial transfer therapy restores function and biogenesis of cells with damaged or dysfunctional mitochondria as well as augments function of healthy cells.
Location: Japan, Chuo
Total raised: $30.3M
Investors 2
| Date | Name | Website |
| - | Fast Track... | us.fasttra... |
| - | J-Startup | j-startup.... |
Mentions in press and media 5
| Date | Title | Description |
| 10.06.2022 | Aiming to harness the power of mitochondria, a Japanese startup nets new funding | One of the basic lessons in science class is that mitochondria act as the powerhouse of the cell. But LUCA Science, a Japanese biotech, is looking to take it a step further. The company is looking to harness the power of mi... |
| 06.06.2022 | 4BIO Capital co-leads $30.3 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science | Press Release 4BIO Capital co-leads $30.3 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science Financing reflects the potential of mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tiss... |
| 03.09.2020 | Axil Capital leads $9.8m funding in Japanese biopharma Luca Science | Premium Tokyo-based venture capital firm Axil Capital has led a $9.8-million Series A funding in Luca Science, a Japanese preclinical biopharmaceutical company that focuses on the discovery of mitochondria therapy to treat diseases and inju... |
| 01.09.2020 | Luca Science Raises $M in Series A Financing | Luca Science, a Tokyo, Japan-based company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of a $9.8m Series A financing. The round was led by A... |
| - | 4BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science | - Financing reflects the potential of mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs |